Search
Amicus Therapeutics Inc
FOLDAdd to Watchlist
14.490USD
0.0000.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.55BMarket Cap
LossP/E TTM
Risk Assessment
Currency: USD Updated: 2026-04-24Amicus Therapeutics Inc’s latest ESG disclosure leads the Biotechnology & Medical Research industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
Beta vs S&P 500 index
0.45
VaR
+4.47%
240-Day Maximum Drawdown
+14.42%
240-Day Volatility
+45.81%
Return
Best Daily Return
60 days
+0.35%
120 days
+30.21%
5 years
+30.21%
Worst Daily Return
60 days
-0.14%
120 days
-3.16%
5 years
-17.18%
Sharpe Ratio
60 days
+3.30
120 days
+2.39
5 years
+0.44
Risk Assessment
Maximum Drawdown
240 days
+14.42%
3 years
+61.16%
5 years
+61.16%
Return-to-Drawdown Ratio
240 days
+9.87
3 years
+0.07
5 years
+0.21
Skewness
240 days
+5.49
3 years
+2.01
5 years
+0.97
Volatility
Realised Volatility
240 days
+45.81%
5 years
+48.91%
Standardised True Range
240 days
+1.53%
5 years
+2.81%
Downside Risk-Adjusted Return
120 days
+979.94%
240 days
+979.94%
Maximum Daily Upside Volatility
60 days
+1.69%
Maximum Daily Downside Volatility
60 days
+1.35%
Liquidity
Average Turnover Rate
60 days
+1.48%
120 days
+1.44%
5 years
--
Turnover Deviation
20 days
+26.69%
60 days
+42.46%
120 days
+38.28%
